Banner

GWAS-related eQTLs across different cancer types

We identified 337,131 eQTLs that overlap with GWAS linkage disequilibrium (LD) regions ( ≥ 0.5).



e.g., "STAD"
e.g., "r²>= 0.8"
e.g., "rs2273"
Cancer type
eQTL type
tagSNP
LD
SNP ID
SNP position (hg19)
Gene symbol
Gene position (hg19)
Beta
t-stat
p-value
GWAS-Traits
BRCA cis rs7692995 1 rs10446630 chr4:17958690 NCAPG chr4:17812525-17846485:+ 0.09 4.2 2.91E-5 Height
BRCA cis rs4660306 1 rs1044717 chr1:45976587 CCDC163P chr1:45960581-45965646:- -0.82 -27.58 7.41E-127 Homocysteine levels
BRCA cis rs4660306 1 rs1044717 chr1:45976587 MMACHC chr1:45965856-45976737:+ -0.14 -3.94 8.83E-5 Homocysteine levels
BRCA cis rs10448080 1 rs10448080 chr8:28604791 CCDC25 chr8:27590835-27630170:- 0.14 3.63 0.000294 Height
BRCA cis rs10448080 1 rs10448080 chr8:28604791 ELP3 chr8:27947749-28048667:+ 0.18 4.6 4.67E-6 Height
BRCA cis rs10448080 1 rs10448080 chr8:28604791 EXTL3 chr8:28559153-28611202:+ 0.13 3.68 0.000249 Height
BRCA cis rs10448080 1 rs10448080 chr8:28604791 FBXO16 chr8:28285930-28347784:- 0.13 3.58 0.000353 Height
BRCA cis rs10448080 1 rs10448080 chr8:28604791 INTS9 chr8:28625180-28747698:- 0.16 4.2 2.93E-5 Height
BRCA cis rs10448080 1 rs10448080 chr8:28604791 ZNF395 chr8:28203104-28347784:- 0.13 4.11 4.22E-5 Height
BRCA cis rs10160456 1 rs10450561 chr11:27309956 LGR4 chr11:27387510-27494334:- -0.14 -4.09 4.69E-5 Bone mineral density (paediatric, skull)
BRCA cis rs10160456 1 rs10450562 chr11:27310006 LGR4 chr11:27387510-27494334:- 0.14 4.09 4.59E-5 Bone mineral density (paediatric, skull)
BRCA cis rs10454142 1 rs10454142 chr2:48646399 GTF2A1L chr2:48844948-48960284:+ -0.22 -5.36 1.03E-7 Sex hormone-binding globulin levels
BRCA cis rs10454142 1 rs10454142 chr2:48646399 KLRAQ1 chr2:48667908-48742524:+ 0.2 4.9 1.11E-6 Sex hormone-binding globulin levels
BRCA cis rs10454142 1 rs10454142 chr2:48646399 STON1-GTF2A1L chr2:48796159-48906746:+ -0.22 -6.17 9.44E-10 Sex hormone-binding globulin levels
BRCA cis rs1577917 1 rs10455158 chr6:86672825 SNHG5 chr6:86386726-86388451:- -0.57 -17.96 3.15E-63 Response to antipsychotic treatment